Evidence map›Paper›PMID 25476903›Full record

ArticleCell death & disease2014

RIPK1 promotes death receptor-independent caspase-8-mediated apoptosis under unresolved ER stress conditions.

Y Estornes, M A Aguileta, C Dubuisson, J De Keyser, V Goossens, K Kersse, A Samali, P Vandenabeele, M J M Bertrand

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.1field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Protein Kinase-Mediated Decision Between the Life and Death.Advances in experimental medicine and biology · 2021
    Article
  14. Review
  15. Review
  16. Type I interferons and endoplasmic reticulum stress in health and disease.International review of cell and molecular biology · 2020
    Review
  17. 24(Cell death discovery · 2019
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Y Estornes1] VIB Inflammation Research Center, Technologiepark 927, Zwijnaarde-Ghent 9052, Belgium [2] Department of Biomedical Molecular Biology, Ghent University, Technologiepark 927, Zwijnaarde-Ghent 9052, Belgium.
M A Aguileta1] VIB Inflammation Research Center, Technologiepark 927, Zwijnaarde-Ghent 9052, Belgium [2] Department of Biomedical Molecular Biology, Ghent University, Technologiepark 927, Zwijnaarde-Ghent 9052, Belgium.
C Dubuisson1] VIB Inflammation Research Center, Technologiepark 927, Zwijnaarde-Ghent 9052, Belgium [2] Department of Biomedical Molecular Biology, Ghent University, Technologiepark 927, Zwijnaarde-Ghent 9052, Belgium.
J De Keyser1] VIB Inflammation Research Center, Technologiepark 927, Zwijnaarde-Ghent 9052, Belgium [2] Department of Biomedical Molecular Biology, Ghent University, Technologiepark 927, Zwijnaarde-Ghent 9052, Belgium.
V Goossens1] VIB Inflammation Research Center, Technologiepark 927, Zwijnaarde-Ghent 9052, Belgium [2] Department of Biomedical Molecular Biology, Ghent University, Technologiepark 927, Zwijnaarde-Ghent 9052, Belgium.
K Kersse1] VIB Inflammation Research Center, Technologiepark 927, Zwijnaarde-Ghent 9052, Belgium [2] Department of Biomedical Molecular Biology, Ghent University, Technologiepark 927, Zwijnaarde-Ghent 9052, Belgium.
A Samali1] Apoptosis Research Center, NUI Galway, Galway, Ireland [2] School of Natural Sciences, NUI Galway, Galway, Ireland.
P Vandenabeele1] VIB Inflammation Research Center, Technologiepark 927, Zwijnaarde-Ghent 9052, Belgium [2] Department of Biomedical Molecular Biology, Ghent University, Technologiepark 927, Zwijnaarde-Ghent 9052, Belgium.
M J M Bertrand1] VIB Inflammation Research Center, Technologiepark 927, Zwijnaarde-Ghent 9052, Belgium [2] Department of Biomedical Molecular Biology, Ghent University, Technologiepark 927, Zwijnaarde-Ghent 9052, Belgium.
Ghent University · BEOllscoil na Gaillimhe – University of Galway · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accumulation of unfolded proteins in the endoplasmic reticulum (ER) causes ER stress and results in the activation of the unfolded protein response (UPR), which aims at restoring ER homeostasis. However, when the stress is too severe the UPR switches from being a pro-survival response to a pro-death one, and the molecular mechanisms underlying ER stress-mediated death have remained incompletely understood. In this study, we identified receptor interacting protein kinase 1 (RIPK1)-a kinase at the crossroad between life and death downstream of various receptors-as a new regulator of ER stress-induced death. We found that Ripk1-deficient MEFs are protected from apoptosis induced by ER stressors, which is reflected by reduced caspase activation and PARP processing. Interestingly, the pro-apoptotic role of Ripk1 is independent of its kinase activity, is not regulated by its cIAP1/2-mediated ubiquitylation, and does not rely on the direct regulation of JNK or CHOP, two reportedly main players in ER stress-induced death. Instead, we found that ER stress-induced apoptosis in these cells relies on death receptor-independent activation of caspase-8, and identified Ripk1 upstream of caspase-8. However, in contrast to RIPK1-dependent apoptosis downstream of TNFR1, we did not find Ripk1 associated with caspase-8 in a death-inducing complex upon unresolved ER stress. Our data rather suggest that RIPK1 indirectly regulates caspase-8 activation, in part via interaction with the ER stress sensor inositol-requiring protein 1 (IRE1).

Indexed as

AnimalsAntibodies, MonoclonalApoptosisCaspase 8DoxycyclineEndoplasmic Reticulum StressEndoribonucleasesFibroblastsGene Expression RegulationHEK293 CellsHumansImidazolesIndolesMiceProtein Kinase InhibitorsProtein Serine-Threonine KinasesAntibodies, MonoclonalCaspase 8DoxycyclineEndoribonucleasesERN1 protein, humanImidazolesIndolesnecrostatin-1Protein Kinase InhibitorsProtein Serine-Threonine KinasesReceptor-Interacting Protein Serine-Threonine KinasesReceptors, Tumor Necrosis Factor, Type IRIPK1 protein, humanRipk1 protein, mouseTnfrsf1a protein, mouseTunicamycin

Identifiers

PMID25476903
PMCPMC4649839
OpenAlexW1965364089

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.